The9 Ltd
NCTY
BIT Mining
BTCM
FRMO CORP
FRMO
Digihost Technology
DGHI
Abits
ABTS
Cassava Sciences, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer’s disease, including PTI-125 and PTI-125Dx. The company was founded by Remi Barbier in May 1998 and is headquartered in Austin, TX.